Comparison of the effects of zafirlucast and montelucast therapy on the airway hiperreactivity in asthmatic patients

I. Akbas, T. Cengiz, B. Musellim, T. Demir, B. Mutlu (Istanbul, Turkey)

Source: Annual Congress 2001 - Factors contributing to upper and lower airway responses
Session: Factors contributing to upper and lower airway responses
Session type: Thematic Poster Session
Number: 2893
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Akbas, T. Cengiz, B. Musellim, T. Demir, B. Mutlu (Istanbul, Turkey). Comparison of the effects of zafirlucast and montelucast therapy on the airway hiperreactivity in asthmatic patients. Eur Respir J 2001; 16: Suppl. 31, 2893

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010


Effects of budesonide/formoterol combination therapy versus budesonide on airway dimensions in asthma
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012

Anti-inflammatory effect and clinical efficacy of concomitant treatments to steroid inhaler in bronchial asthma: montelukast versus salmeterol
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006

The bronchodilatory effect of NVA237 inhaled once daily in patients with COPD
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010

Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

Combined treatment with fluticasone plus salmeterol protects against allergen-induced asthmatic responses better than each drug alone
Source: Eur Respir J 2001; 18: Suppl. 33, 349s
Year: 2001

Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

Inhaled budesonide/formoterol combination therapy significantly attenuates allergen-induced increases in airway myfibroblasts
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007

The effect of fluticasone vs fluticasone plus salmeterol on allergen-induced bronchial inflammation in asthmatic patients. A long-term RCT
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma
Source: Eur Respir J 2001; 17: 374-379
Year: 2001



Efficacy of symbicort administration in patients with bronchial asthma
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009


Effects of acute dual bronchodilator treatment (tiotropium + olodaterol) on cardiopulmonary interactions in hyperinflated patients with COPD
Source: International Congress 2018 – Advances in exercise physiopathology
Year: 2018



Safety of formoterol reliever therapy compared with terbutaline in asthmatic children taking anti-inflammatory therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 431s
Year: 2002

Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016


Effect of fluticasone and formoterol combination therapy on airway remodeling
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011


The effect of combined β2-agonist and anticholinergic inhaled therapy in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 341s
Year: 2004

Efficacy of long-term formoterol therapy vs as-needed salbutamol use in patients with moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 426s
Year: 2001

Evening administration of tiotropium during combination therapy reduces night-symptoms in COPD patients
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008


Once-daily QVA149 improves lung function and dyspnoea compared with tiotropium plus formoterol: The QUANTIFY study
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Response to salbutamol in patients with mild asthma treated with nadolol
Source: Eur Respir J 2010; 36: 963-965
Year: 2010